Cyclic Peptide Formation in Reduced Solvent Volumes via In-Line Solvent Recycling by Organic Solvent Nanofiltration

Abstract

Cyclic peptides have found numerous and wide ranging applications that include drug molecules, nanomaterials, and chiral chromatography stationary phases. However, in the crucial cyclization step, high dilution conditions are often required, resulting in large volumes of solvent being consumed to prepare relatively small quantities of product. This paper demonstrates the synthesis of a cyclic nonapeptide with in-line solvent recycling via organic solvent nanofiltration (OSN) resulting in a significant reduction in the solvent load of the reaction and concomitant improvement in process mass intensification (PMI). The membrane was used to remove the reaction product from the reaction vessel, as the cyclic peptide product shows limited stability in the presence of an excess of reaction reagent. In comparison to the standard batch reaction, no loss in yield or product purity was observed for the OSN process tested. The proof-of-concept study outlined in this paper was performed on a real active pharmaceutical ingredient (API), and the technique used is widely applicable and flexible.

Sustainability Challenges in Peptide Synthesis and Purification: From R&D to Production

“…Indications were seen in this work for potential to reduce the high solvent waste burden produced during peptide manufacture. This solvent waste reduction has been further investigated and demonstrated by a separate group in the context of a high-dilution peptide cyclization reaction …”

Solvent recycle with imperfect membranes: A semi-continuous workaround for diafiltration

“…There are exceptions where solvent recovery was used in settings where some permeation of solutes is permissible, usually in closed-loop configurations. Examples include a recent cyclisation of a peptide in a high dilution reactor [10] and the MAX-DEWAX process for recovery of chilled solvent from lube oil filtrates after dewaxing [13]. These and further applications such as recovery of extraction solvents e.g.…”

Greening the synthesis of peptide therapeutics: an industrial perspective

“…Hence, LPPS and MEPS have the potential to signicantly reduce reagent consumption compared to standard SPPS. The volumes of solvent typically required for ltration in MEPS are currently high and would need further optimisation to reduce overall solvent use, but solvent nanoltration can also facilitate organic solvent recycling in peptide API production, 121 which is especially important if problematic solvents, such as DMF, chloroform or THF are used, and would further remove the need for repeated precipitation/wash cycles in LPPS that might be unpractical on scale. Initial efforts for solvent replacement in LPPS have been made, e.g.…”